Video Interpretation of Phase II Clinical Trial Results of Project NHT210118
Time:2021-12-08 05:32:17
hits:9310
Recommended reading
-
Subject Recruitment Advertisement for Phase III Clinical Study of Therapeutic (Synthetic Peptide) Hepatitis B Vaccine (NHT210118)
-
Novel Peptide Bioscience Co., Ltd. Acquires Jiangsu Mendel Gene Technology Co., Ltd.